These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38917598)

  • 1. CD69
    You H; Wang Y; Wang X; Zhu H; Zhao Y; Qin P; Liu X; Zhang M; Fu X; Xu B; Zhang Y; Wang Z; Gao Q
    Mol Immunol; 2024 Aug; 172():76-84. PubMed ID: 38917598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased CD4(+) CD69(+) CD25(-) T cells in patients with hepatocellular carcinoma are associated with tumor progression.
    Zhu J; Feng A; Sun J; Jiang Z; Zhang G; Wang K; Hu S; Qu X
    J Gastroenterol Hepatol; 2011 Oct; 26(10):1519-26. PubMed ID: 21557772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
    Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J
    Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of peripheral CD3
    Zhang S; Li L; Liu C; Pu M; Ma Y; Zhang T; Chai J; Li H; Yang J; Chen M; Kong L; Xia T
    J Cancer Res Clin Oncol; 2024 Jul; 150(7):365. PubMed ID: 39052085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal Cell Carcinoma-Infiltrating CD3
    Lee HW; Park C; Joung JG; Kang M; Chung YS; Oh WJ; Yeom SY; Park WY; Kim TJ; Seo SI
    Curr Issues Mol Biol; 2021 May; 43(1):226-239. PubMed ID: 34071865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human hepatocellular carcinoma-infiltrating CD4⁺CD69⁺Foxp3⁻ regulatory T cell suppresses T cell response via membrane-bound TGF-β1.
    Han Y; Yang Y; Chen Z; Jiang Z; Gu Y; Liu Y; Xu S; Lin C; Pan Z; Zhou W; Cao X
    J Mol Med (Berl); 2014 May; 92(5):539-50. PubMed ID: 24668348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma-infiltrating γδ T cells are functionally defected and allogenic Vδ2
    He W; Hu Y; Chen D; Li Y; Ye D; Zhao Q; Lin L; Shi X; Lu L; Yin Z; He X; Gao Y; Wu Y
    Clin Transl Med; 2022 Apr; 12(4):e800. PubMed ID: 35390227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are non-traditional CD4(+) CD69(+) CD25(-) regulatory T cells involved in disease progression of human hepatocellular carcinoma?
    Xu D; Wang FS
    J Gastroenterol Hepatol; 2011 Oct; 26(10):1469-70. PubMed ID: 21950742
    [No Abstract]   [Full Text] [Related]  

  • 9. Decrease of CD69 levels on TCR Vα7.2
    Yong YK; Tan HY; Saeidi A; Rosmawati M; Atiya N; Ansari AW; Rajarajeswaran J; Vadivelu J; Velu V; Larsson M; Shankar EM
    Innate Immun; 2017 Jul; 23(5):459-467. PubMed ID: 28606013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrahepatic CD69
    Bruni E; Cimino MM; Donadon M; Carriero R; Terzoli S; Piazza R; Ravens S; Prinz I; Cazzetta V; Marzano P; Kunderfranco P; Peano C; Soldani C; Franceschini B; Colombo FS; Garlanda C; Mantovani A; Torzilli G; Mikulak J; Mavilio D
    J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35863820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression on the Roles and Mechanisms of Tumor-Infiltrating T Lymphocytes in Patients With Hepatocellular Carcinoma.
    Zheng X; Jin W; Wang S; Ding H
    Front Immunol; 2021; 12():729705. PubMed ID: 34566989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma.
    Garnelo M; Tan A; Her Z; Yeong J; Lim CJ; Chen J; Lim KH; Weber A; Chow P; Chung A; Ooi LL; Toh HC; Heikenwalder M; Ng IO; Nardin A; Chen Q; Abastado JP; Chew V
    Gut; 2017 Feb; 66(2):342-351. PubMed ID: 26669617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokine receptors support infiltration of lymphocyte subpopulations in human hepatocellular carcinoma.
    Liu Y; Poon RT; Hughes J; Feng X; Yu WC; Fan ST
    Clin Immunol; 2005 Feb; 114(2):174-82. PubMed ID: 15639651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential Expression of Programmed Death Ligand 1 Protein in Tumor-Associated Macrophages and Its Potential Role in Immunotherapy for Hepatocellular Carcinoma.
    Park DJ; Sung PS; Lee GW; Cho S; Kim SM; Kang BY; Hur W; Yang H; Lee SK; Lee SH; Jung ES; Seo CH; Ahn J; Choi HJ; You YK; Jang JW; Bae SH; Choi JY; Yoon SK
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-cell data revealed exhaustion of characteristic NK cell subpopulations and T cell subpopulations in hepatocellular carcinoma.
    Cui Z; Li H; Liu C; Wang J; Chen C; Hu S; Zhao X; Li G
    Aging (Albany NY); 2024 Apr; 16(7):6550-6565. PubMed ID: 38604154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vgamma9Vdelta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas.
    Bouet-Toussaint F; Cabillic F; Toutirais O; Le Gallo M; Thomas de la Pintière C; Daniel P; Genetet N; Meunier B; Dupont-Bierre E; Boudjema K; Catros V
    Cancer Immunol Immunother; 2008 Apr; 57(4):531-9. PubMed ID: 17764010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Off-the-shelf Vδ1 gamma delta T cells engineered with glypican-3 (GPC-3)-specific chimeric antigen receptor (CAR) and soluble IL-15 display robust antitumor efficacy against hepatocellular carcinoma.
    Makkouk A; Yang XC; Barca T; Lucas A; Turkoz M; Wong JTS; Nishimoto KP; Brodey MM; Tabrizizad M; Gundurao SRY; Bai L; Bhat A; An Z; Abbot S; Satpayev D; Aftab BT; Herrman M
    J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34916256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 14-3-3ζ delivered by hepatocellular carcinoma-derived exosomes impaired anti-tumor function of tumor-infiltrating T lymphocytes.
    Wang X; Shen H; Zhangyuan G; Huang R; Zhang W; He Q; Jin K; Zhuo H; Zhang Z; Wang J; Sun B; Lu X
    Cell Death Dis; 2018 Feb; 9(2):159. PubMed ID: 29415983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
    Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
    Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The functional impairment of HCC-infiltrating γδ T cells, partially mediated by regulatory T cells in a TGFβ- and IL-10-dependent manner.
    Yi Y; He HW; Wang JX; Cai XY; Li YW; Zhou J; Cheng YF; Jin JJ; Fan J; Qiu SJ
    J Hepatol; 2013 May; 58(5):977-83. PubMed ID: 23262246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.